|
|
|
|
|
|
Without the pharmaceutical industry, the EU trade balance would shift from a €147 billion surplus to a €47 billion deficit, leaving Europe more exposed to external dependencies.
|
|||||
|
|
09 February 2026
Digital Medicines Information gains momentum
A new report from AESGP, EFPIA and Medicines for Europe provides a comprehensive overview of electronic Product Information...
|
||
|
|
|
Building trustworthy 21st century healthcare systems: Results from the OECD Patient...
Online
Join this OECD webinar, which explores the findings presented in Chapter 6 of the PaRIS flagship report, highlighting... Learn more → |
|||
|
|
J&J | The essentials of partnering with a pharma company
Utrecht & Virtual
Discover what it takes to build successful collaborations with pharmaceutical companies and accelerate your innovation... Learn more → |
|||
|
|
‘Saving Lives’: Comic book combines science & storytelling
05 February 2026 (Vaccines Today)
When an epidemic on a Pacific island sparks fears of a global pandemic, a heroic Belgian scientist with the help...
|
|
From ambition to delivery – An urgent call for action in 2026
05 February 2026 (Business Europe)
In the run-up to the European elections in 2024, BusinessEurope called for a “REBOOT” in European policies, focussing...
|
|
Making the manufacturing of medical products better with IHI and IMI
30 January 2026 (IHI)
Europe’s competitiveness and health resilience will improve thanks to strides made by IHI and IMI projects in medical...
|
|
Measles in Europe: How to get back on track
28 January 2026 (Vaccines Today)
Measles is circulating in 25% of countries in the WHO’s 53-member European region. It has made an unwelcome return...
|
|
The state of cardiovascular health in the European Union
15 December 2025 (OECD)
Cardiovascular disease (CVD) remains the leading cause of death and disability in the European Union, with significant...
|
|
|||
|
|||||
|
EFPIA 2026 All rights reserved ·
Disclaimer
·
|